EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of 5 years of hepatitis C testing and treatment in the North East of England prisons

Amy Johnson iD, Jessica Shearer, Craig Thompson, Ryan Jelley, Jodi Aldridge, Caroline Allsop, Jenna Kerry, Dee Jones, Francesca McCullough, Carolyn Miller, Manoj Valappil, Yusri Taha und 5 weitere

Journal of Viral Hepatitis · 2023-12 · 30 (12) · 914-921

DOI: 10.1111/jvh.13887 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, online erschienen am 12.09.2023. Verfasst von Amy Johnson und 16 weiteren Autor:innen. Beteiligte Einrichtung: Liver Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Substance Abuse, Intravenous, Hepatitis C, Prisoners. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis C virus infection (HCV) is prevalent in prisons. Therefore, effective prison HCV services are critical for HCV elimination programmes. We aimed to evaluate the efficacy of a regional HCV prison testing and treatment programme. Between July 2017 and June 2022, data were collected prospectively on HCV test offer and uptake rates, HCV Antibody (HCV‐Ab) and HCV‐RNA positivity, treatment starts and outcomes for new inmates incarcerated in three prisons. Rates of HCV‐Ab and RNA positivity at reception, incidence of new HCV infections and reinfection following treatment were determined. From a total of 39,652 receptions, 33,028 (83.3%) were offered HCV testing and 20,394 (61.7%) completed testing. Including all receptions, 24.5% of tests ( n = 4995) were HCV‐Ab positive and 8.4% of tests ( n = 1713) were HCV‐RNA positive. When considering the first test for each individual (median age 34 years; 88.1% male), 14.8% ( n = 1869) and 7.2% ( n = 905) were HCV‐Ab and HCV‐RNA positive, respectively. The incidence of new HCV‐Ab and RNA positivity was 5.1 and 3.3 per 100 person‐years, respectively. Of 1145 HCV viraemic individuals, 18 died within 6 months and 150 were rapidly transferred out of area, leaving 977 individuals with outcomes. Of these, 835 (85.5%) received antivirals and 47 spontaneously cleared the infection, leaving 95 (9.7%) untreated. 607 (72.7%) achieved SVR. 95 patients had reinfection post‐treatment (rate 10.1 cases per 100 person‐years). Testing for HCV has increased in our prisons and the majority with viraemia are initiated on antiviral treatment. Reassuringly, a significant fall in frequency of HCV‐RNA positivity at prison reception was observed suggesting progress towards HCV elimination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance Abuse, IntravenousHepatitis CPrisonersHumansMaleAdultFemalePrisonsReinfectionHepacivirusRNAEnglandHepatitis C AntibodiesAntiviral Agents

Stichwörter der Autor:innen

direct acting antiviral treatmenthepatitis C virusincidenceinjecting drug usereinfection

Substanzen

RNAHepatitis C AntibodiesAntiviral Agents

Autor:innen und Institutionen

  • Liver Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Spectrum Community Health, Wakefield, UK.
  • Department of Microbiology and Virology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Hepatitis C Trust, London, UK.

ORCID-Profile: Amy Johnson, Steven Masson, Stuart McPherson

Zitieren

APA

Johnson, A., Shearer, J., Thompson, C., Jelley, R., Aldridge, J., Allsop, C., Kerry, J., Jones, D., McCullough, F., Miller, C., Valappil, M., Taha, Y., Masson, S., Jefferson, T., Lawton, C., Christensen, L., & McPherson, S. (2023). Impact of 5 years of hepatitis C testing and treatment in the North East of England prisons. Journal of Viral Hepatitis, 30(12), 914-921. https://doi.org/10.1111/jvh.13887

Vancouver

Johnson A, Shearer J, Thompson C, Jelley R, Aldridge J, Allsop C, et al. Impact of 5 years of hepatitis C testing and treatment in the North East of England prisons. Journal of Viral Hepatitis. 2023;30(12):914-921. doi:10.1111/jvh.13887

BibTeX
@article{Johnson2023,
  author = {Johnson, Amy and Shearer, Jessica and Thompson, Craig and Jelley, Ryan and Aldridge, Jodi and Allsop, Caroline and Kerry, Jenna and Jones, Dee and McCullough, Francesca and Miller, Carolyn and Valappil, Manoj and Taha, Yusri and Masson, Steven and Jefferson, Tony and Lawton, Colin and Christensen, Lee and McPherson, Stuart},
  title = {Impact of 5 years of hepatitis C testing and treatment in the North East of England prisons},
  journal = {Journal of Viral Hepatitis},
  year = {2023},
  volume = {30},
  number = {12},
  pages = {914--921},
  doi = {10.1111/jvh.13887}
}
Kostenlos starten →